ESSA Pharma Inc (EPIX)
6.88
-0.07
(-1.01%)
USD |
NASDAQ |
May 03, 16:00
6.97
+0.09
(+1.31%)
After-Hours: 20:00
ESSA Pharma Cash from Financing (Quarterly): 0.1967M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1967M |
| September 30, 2023 | -0.0136M |
| June 30, 2023 | -0.0355M |
| March 31, 2023 | -0.0346M |
| December 31, 2022 | 0.0157M |
| September 30, 2022 | -0.0346M |
| June 30, 2022 | 0.0049M |
| March 31, 2022 | 0.1831M |
| December 31, 2021 | 0.0993M |
| September 30, 2021 | 0.0133M |
| June 30, 2021 | 0.1892M |
| March 31, 2021 | 141.64M |
| December 31, 2020 | 0.1509M |
| September 30, 2020 | 45.77M |
| June 30, 2020 | 0.0513M |
| March 31, 2020 | -0.0094M |
| December 31, 2019 | -4.036M |
| September 30, 2019 | 53.60M |
| June 30, 2019 | -1.433M |
| March 31, 2019 | -0.8027M |
| December 31, 2018 | -0.8027M |
| Date | Value |
|---|---|
| September 30, 2018 | -0.8027M |
| June 30, 2018 | -0.7974M |
| March 31, 2018 | 23.06M |
| December 31, 2017 | -0.1466M |
| September 30, 2017 | -0.3586M |
| June 30, 2017 | -0.2033M |
| March 31, 2017 | 5.059M |
| December 31, 2016 | 7.830M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.2171M |
| March 31, 2016 | 19.19M |
| December 31, 2015 | 3.768M |
| September 30, 2015 | 0.0109M |
| June 30, 2015 | 0.1197M |
| March 31, 2015 | 10.38M |
| December 31, 2014 | 2.084M |
| September 30, 2014 | 4.743M |
| June 30, 2014 | 0.9152M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.036M
Minimum
Dec 2019
141.64M
Maximum
Mar 2021
12.44M
Average
0.0157M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| Acasti Pharma Inc | 0.00 |
| Aurinia Pharmaceuticals Inc | -5.577M |
| Edesa Biotech Inc | 0.3057M |
| Lexaria Bioscience Corp | 3.453M |
| Xenon Pharmaceuticals Inc | 324.01M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.787M |
| Cash from Investing (Quarterly) | 8.232M |
| Free Cash Flow | -22.19M |
| Free Cash Flow Per Share (Quarterly) | -0.1538 |
| Free Cash Flow Yield | -7.31% |